ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,522.30
      1.58%
      US Tech 100
      19,014.40
      3.90%
      Dow Jones
      40,842.79
      0.24%
      Brent Oil
      81.165
      -0.42%
      Bitcoin
      63,953.23
      -1.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Bausch plus Lomb Corporation (BLCO) Quote

      Bausch plus Lomb Corporation

      Bausch plus Lomb Corporation (BLCO)

      Bausch and Lomb Corporation
      Bausch and Lomb Corporation
      Bausch and Lomb Corporation
      17.22
      0.35
      (2.07%)
      Closed July 31 4:00PM
      Delayed by 15 minutes
      17.22
      0.00
      (0.00%)
      After Hours: 7:55PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      17.22
      Bid
      -
      Ask
      -
      Volume
      1,568,760
      16.57 Day's Range 17.50
      13.16 52 Week Range 20.30
      Market Cap
      6.053B
      Previous Close
      16.87
      Open
      16.57
      Last Trade
      300
      @
      17.22
      (formt)
      Last Trade Time
      Financial Volume
      $ 26,850,802
      VWAP
      17.1159
      Average Volume (3m)
      519,035
      Shares Outstanding
      351,482,100
      Dividend Yield
      -
      PE Ratio
      -32.22
      Earnings Per Share (EPS)
      -0.74
      Revenue
      4.15B
      Net Profit
      -260M

      About Bausch plus Lomb Corporation

      Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a pu... Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Show more

      Sector
      Offices Of Optometrists
      Industry
      Offices Of Optometrists
      Headquarters
      Toronto, Ontario, Can
      Founded
      1970
      Bausch plus Lomb Corporation is listed in the Offices Of Optometrists sector of the New York Stock Exchange with ticker BLCO. The last closing price for Bausch plus Lomb was $16.87. Over the last year, Bausch plus Lomb shares have traded in a share price range of $ 13.16 to $ 20.30.

      Bausch plus Lomb currently has 351,482,100 shares outstanding. The market capitalization of Bausch plus Lomb is $5.93 billion. Bausch plus Lomb has a price to earnings ratio (PE ratio) of -32.22.

      BLCO Latest News

      More News

      Form 8-K - Current report

      16 hours ago
      Edgar (US Regulatory)

      Bausch + Lomb Announces Second-Quarter 2024 Results

      Revenue of $1.216 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $151 Million Adjusted EBITDA (non-GAAP)1 of $209 Million Revenue Grew 17% as Reported and 20% on a Constant...

      16 hours ago
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      July 29 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 29 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 29 2024
      Edgar (US Regulatory)

      Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on...

      July 11 2024
      Business Wire

      Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

      New Online Resource, KnowYourDryEye.com, Aims to Increase Awareness and Education Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see...

      July 08 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 18 2024
      Edgar (US Regulatory)

      Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

      Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye...

      June 17 2024
      Business Wire

      Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

      Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of Bausch + Lomb...

      June 10 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.251.4731879787916.9717.514.05210323816.29859827CS
      42.5217.142857142914.717.514.0588842616.33182238CS
      122.5317.222600408414.6917.514.0551903515.76359653CS
      262.9220.419580419614.317.69513.1651366415.49563816CS
      52-2.6-13.118062563119.8220.313.1650502516.01659709CS
      156-1.28-6.9189189189218.521.9512.261098216.34747044CS
      260-1.28-6.9189189189218.521.9512.261098216.34747044CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BEDUBright Scholar Education Holdings Limited
      $ 2.20
      (33.33%)
      		79.13k
      CCMConcord Medical Services Holdings Ltd
      $ 7.875
      (27.02%)
      		213.98k
      FVRRFiverr International Ltd
      $ 26.10
      (19.23%)
      		3.21M
      MODModine Manufacturing Co
      $ 117.67
      (18.95%)
      		2.36M
      PSNParsons Corporation
      $ 91.36
      (18.37%)
      		4.13M
      ANROAlto Neuroscience Inc
      $ 10.77
      (-21.56%)
      		1.21M
      CHCTCommmunity Healthcare Trust
      $ 21.79
      (-20.79%)
      		1.15M
      LMNDLemonade Inc
      $ 18.04
      (-20.28%)
      		6.25M
      CBZCBIZ Inc
      $ 69.39
      (-19.33%)
      		1.72M
      FEDUFour Seasons Education Cayman Inc
      $ 12.9501
      (-19.06%)
      		2.87k
      LUMNLumen Technologies Inc
      $ 3.1451
      (17.79%)
      		75.98M
      FFord Motor Company
      $ 10.8199
      (-0.19%)
      		75.48M
      ABEVAmbev SA
      $ 2.06
      (-1.44%)
      		60.96M
      BACBank of America Corporation
      $ 40.31
      (-2.35%)
      		50.85M
      KVUEKenvue Inc
      $ 18.48
      (-1.44%)
      		42.06M

      BLCO Discussion

      View Posts
      Zilla Zilla 3 months ago
      Good ER but stock dived down, bounced up and down again...Hit 13.64 and closed 13.74
      So that golden cross might be off the table unless it pops tomorrow if BHC doesn't distribute in 2024...
      👍️0
      Zilla Zilla 3 months ago
      Almost another year later and 88.7% of BLCO is still with BHC almost 2 years after the IPO just before the ER...
      Currently BLCO is 14.79 with less than 5% short interest...10.5% Inst owned...
      BHC is @ 8.71 72% inst/owned about 12% short interest...
      Norwich lost in court recently and BHC had hit 11.46 a little before the verdict on a quick POP and it's been dropping ever since. Didn't break below the 200DMA of 8.30 but tested the 8.50's often...
      👍️0
      Zilla Zilla 3 months ago
      BLCO @ 14.79 with ER next week...
      200DMA 16.53
      50DMA 15.89
      Golden Cross may be heading our way...If the ER sends us up and BHC doesn't announce a distribution...
      👍️0
      Zilla Zilla 5 months ago
      Good ER and more than a buck higher open it looks like. I sold too soon as always and also I sold a 100 calls so that's about 20,000 I would have gotten more had I held 1 day longer. Still got my 'core' of calls that are good til there end of the year but these results are really good. Stock should be fine moving forward until BHC shareholders get the BLCO shares and then it will probably sell off but recover and make new highs at some point. =)
      👍️0
      Zilla Zilla 5 months ago
      Sold all 10,000 BLCO above 14.50 just a few cents higher than my cost after flipping so many times. Have good chunk of calls both ITM and not. Just felt I had WAY too much in one stock with all these M&A deals it seems like a 'top' is incoming. So as of now I'm about 20% in calls and 80% in cash... Was 15% cash and 85% invested this morning. Good luck tomorrow and the chart looks really good to run to 17's in the coming weeks as long as tomorrow doesn't surprise to the downside.
      👍️0
      Zilla Zilla 6 months ago
      Yesterday BLCO hit 14.66. I sold a good chunk @ 14.50 even though I wanted to keep it but got it back today @14
      Chart looking like a nice set up into and after earnings next week. We shall see but I've flipped enough times and lowered my average so I'm feeling good. If it tanks on news of BHC shareholders getting BLCO stock my BHC will rise/rocket and I can either hold that for the BLCO shares or trade them accordingly being I already have BLCO shares. Or buy the shares back into BHC and that works too. Stock too cheap down here under 15
      👍️0
      Zilla Zilla 6 months ago
      Today BLCO made new 52 week low of 13.85 currently at 14 with BHC at 8....Something has changed between these two stocks. lol
      I still think both are undervalued and stuck together. Needed to either give BHC shareholders the 80% BLCO shares or...Reverse Merge or buy back BLCO. At 14 for BLCO they could gobble it right back up and the spin at least let them pay down some debt when distressed the past year and a half.
      BLCO at 14 feels like a spin of the 50.1% is coming this year but who knows...ER's should be this month and hopefully BOTH stocks rise up to new 52 week highs but you never know. lol
      👍️0
      Zilla Zilla 1 year ago
      Today BLCO buys XIIDRA from NVS and makes new all time high of 21.95
      BHC went up to 8.22 and closed at 8
      So the future 'growth' will be the BLCO asset and getting 80% of the company in BHC shareholders hands. BHC is 7% short interest as BLCO is over 17 and stock is just above 20...
      I think both are undervalued
      👍️0
      Zilla Zilla 1 year ago
      1 year later not so much. lol Though 88.7% of BLCO is still with BHC over a year after the IPO...BS!
      Currently about 18.50 for BLCO with 19% short interest and almost 13% Inst/own...
      BHC I use to see under 10% short interest but I double taked when I saw 37.22% short interest (as of 5/31/23 and 66% Inst/own trading at 7.19 today. WTF?!? That's some SERIOUS Shorts...Also seems kind of fishy with the 5/17 judge ruling in BHC favor sending the stock from 6 to 9 in days...Only to have Norwich sue the FDA to overrule the courts news on 6/6/23 with the stock breaking below 8 the day before and then breaking below 7... I think a lawsuit and an investigation is in order.
      👍️0
      Zilla Zilla 2 years ago
      Well now we will see what B&L can do away from BHC/VRX
      👍️0
      weedtrader420 weedtrader420 2 years ago
      BLCO$ Cross Eyed Mary
      👍️0
      weedtrader420 weedtrader420 2 years ago
      BLCO$
      👍️0

      Your Recent History

      NYSE
      BLCO
      Bausch plus Lomb
      Delayed Upgrade Clock